Back when former President Donald Trump came down with COVID-19 in October 2020, the world was a lot different than today, when the White House announced President Joe Biden had contracted the illness.
Scientists in Trump’s era were still looking for the best ways to treat the disease, and rates of severe illness and death were much higher. Trump received the highest standard of care any American could hope to get, but these were the earliest tools at hand.
They included a then-experimental monoclonal antibody cocktail from Regeneron Pharmaceuticals Inc. At Walter Reed National Military Medical Center, where he was hospitalized for three nights, he also received the steroid dexamethasone and Gilead Sciences Inc.’s infused antiviral remdesivir.
